» Articles » PMID: 12829246

Management of Cellular Energy by the AMP-activated Protein Kinase System

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2003 Jun 28
PMID 12829246
Citations 298
Authors
Affiliations
Soon will be listed here.
Abstract

The AMP-activated protein kinase is a sensor of cellular energy status that is found in all eukaryotic cells. It is activated by rising AMP and falling ATP by a complex mechanism that results in an ultrasensitive response. The functions of the different domains on the three subunits of the alphabetagamma heterotrimer are slowly being unravelled, and a recent development has been the identification of a glycogen-binding domain on the beta subunit. Along with findings that high cellular glycogen represses kinase activation, this suggests that the system may be a sensor of glycogen content as well as of AMP and ATP. New insights have been obtained into the sequence and structural features by which the kinase recognises its downstream target proteins, and these are discussed. Once activated by depletion of cellular energy reserves, the kinase switches on ATP-producing catabolic pathways and switches off ATP-consuming processes, both via direct phosphorylation of regulatory proteins and via indirect effects on gene expression. A survey of the range of downstream targets for this important signalling pathway is presented.

Citing Articles

[F]FDG-PET and [F]MPPF-PET are brain biomarkers for the creatine transporter Slc6a8 loss of function mutation.

Day I, Tamboline M, Lueptow L, Zhuravka I, Diep T, Tkachyova I Sci Rep. 2025; 15(1):7280.

PMID: 40025148 PMC: 11873236. DOI: 10.1038/s41598-025-92022-8.


New Insights into AMPK, as a Potential Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatic Fibrosis.

An H, Jang Y, Choi J, Hur J, Kim S, Kwon Y Biomol Ther (Seoul). 2024; 33(1):18-38.

PMID: 39702310 PMC: 11704404. DOI: 10.4062/biomolther.2024.188.


Metformin Prevents Tumor Cell Growth and Invasion of Human Hormone Receptor-Positive Breast Cancer (HR+ BC) Cells via Inhibition.

Song C, Jung D, Kendi A, Rho J, Kim E, Horn I Int J Mol Sci. 2024; 25(13).

PMID: 39000600 PMC: 11242876. DOI: 10.3390/ijms25137494.


miR-338-5p regulated the NF-κB/MAPK pathway to alleviate inflammation and oxidative stress by targeting IL-6 in rats with atrial fibrillation.

Zhang Y, Yao Y, Wei J, Zhang Z 3 Biotech. 2024; 14(7):182.

PMID: 38947734 PMC: 11213847. DOI: 10.1007/s13205-024-04024-4.


Xanthine oxidoreductase inhibition ameliorates high glucose-induced glomerular endothelial injury by activating AMPK through the purine salvage pathway.

Yang K, Park H, Chang Y, Park C, Kim S, Hong Y Sci Rep. 2024; 14(1):11167.

PMID: 38750091 PMC: 11096301. DOI: 10.1038/s41598-024-61436-1.